The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target.
The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target.
复制标题
DOI:
10.3390/cells12121605
复制
发表时间:
2023-06-11
期刊:
影响因子:
6
通讯作者:
Kurokawa, Manabu
中科院分区:
文献类型:
--
作者:
Feng, William W.;Zuppe, Hannah T.;Kurokawa, Manabu
关键词:
Cluster of differentiation 36 (CD36) is a cell surface scavenger receptor that plays critical roles in many different types of cancer, notably breast, brain, and ovarian cancers. While it is arguably most well-known for its fatty acid uptake functions, it is also involved in regulating cellular adhesion, immune response, and apoptosis depending on the cellular and environmental contexts. Here, we discuss the multifaceted role of CD36 in cancer biology, such as its role in mediating metastasis, drug resistance, and immune evasion to showcase its potential as a therapeutic target. We will also review existing approaches to targeting CD36 in pre-clinical studies, as well as discuss the only CD36-targeting drug to advance to late-stage clinical trials, VT1021. Given the roles of CD36 in the etiology of metabolic disorders, such as atherosclerosis, diabetes, and non-alcoholic fatty liver disease, the clinical implications of CD36-targeted therapy are wide-reaching, even beyond cancer.
登录
查看更多内容
影响因子:
5.9
作者:
Balaban S;Shearer RF;Lee LS;van Geldermalsen M;Schreuder M;Shtein HC;Cairns R;Thomas KC;Fazakerley DJ;Grewal T;Holst J;Saunders DN;Hoy AJ
通讯作者:
Hoy AJ
影响因子:
8.8
作者:
Feng, William W.;Wilkins, Owen;Kurokawa, Manabu
通讯作者:
Kurokawa, Manabu
影响因子:
3.7
作者:
Geloen A;Helin L;Geeraert B;Malaud E;Holvoet P;Marguerie G
通讯作者:
Marguerie G
影响因子:
8
作者:
Daquinag AC;Gao Z;Fussell C;Immaraj L;Pasqualini R;Arap W;Akimzhanov AM;Febbraio M;Kolonin MG
通讯作者:
Kolonin MG
影响因子:
29
作者:
Corbet, Cyril;Pinto, Adan;Feron, Olivier
通讯作者:
Feron, Olivier